LFM-A13 is a novel anti-leukemic agent targeting Brutons tyrosine kinase (BTK). LFM-A13 is a BTK inhibitor. Molecular Formula: C11H8Br2N2O2 Molecular Weight: 360 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
360
CAS Nummer:
[62004-35-7]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
